ARCHIVES

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Newell, Fredrickson Question Ethics Of Laetrile Trials

July 22, 1977

Amgen Says ESA Use Dropped By Half In Fourth Quarter.

January 25, 2008

Case Western Wins Renewal.

October 5, 2001

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 5, 1974

Animal Problems May Stop NIC Construction Grant To city Of Hope

September 13, 1985

CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments

January 8, 1982